Evidence map›Paper›PMID 40206711›Full record

ArticleHealth science reports2025

A Retrospective Analysis of Changes in Respiratory Pathogens During the Influenza Season Before and After the Relaxation of Non-Pharmaceutical Intervention Policies.

Lin Zhang, Xiang Long, Yun-Ju Yuan, Su-Li Zhao

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lin ZhangDepartment of Laboratory Medicine, Yichang Central People's Hospital, The First College of Clinical Medical Science China Three Gorges University Yichang China.
Xiang LongDepartment of Laboratory Medicine, Yichang Central People's Hospital, The First College of Clinical Medical Science China Three Gorges University Yichang China.
Yun-Ju YuanDepartment of Laboratory Medicine, Yichang Central People's Hospital, The First College of Clinical Medical Science China Three Gorges University Yichang China.
Su-Li ZhaoDepartment of Stomatology, Affiliated Renhe Hospital China Three Gorges University Yichang Hubei China.ORCID 0000-0002-9612-6585

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: The COVID-19 pandemic has profoundly impacted the transmission dynamics and epidemiology of respiratory pathogens, primarily due to non-pharmaceutical interventions (NPIs). This study aims to evaluate the effects of NPIs on the characteristics of winter respiratory pathogens. Methods: This study involved the collection of respiratory pathogen test results from all patients tested at our hospital during two distinct periods: September 2021 to May 2022 and September 2022 to May 2023. The comparison of positive rates was performed using the Results: The predominant pathogen during the 2021/2022 flu seasons was identified as Inf B (1095/9309, 11.76%). Conversely, during the 2022/2023 flu seasons, Inf A emerged as the most prevalent pathogen (4040/18,770, 21.52%). Notably, the positive rates of parainfluenza virus and Conclusions: The findings of this study suggest that the relaxation of NPIs has a notable influence on the transmission of certain respiratory pathogens within the population. We propose the implementation of ongoing surveillance to monitor the epidemiology and evolutionary dynamics of various respiratory pathogens, particularly in situations where NPIs are no longer necessary.

Indexed as

COVID‐19 pandemicinfluenzaNPIsrespiratory pathogensSARS‐CoV‐2

Identifiers

PMID40206711
PMCPMC11980091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.